Haan, Germany

Cristina Alonso-Alija

USPTO Granted Patents = 20 

 


Average Co-Inventor Count = 9.7

ph-index = 13

Forward Citations = 792(Granted Patents)


Company Filing History:


Years Active: 2004-2010

Loading Chart...
Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Cristina Alonso-Alija

Introduction: Cristina Alonso-Alija is an esteemed inventor based in Haan, Germany, recognized for her significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 20 patents, Cristina has demonstrated her commitment to advancing medical science through innovative solutions.

Latest Patents: Among her latest patents, Cristina has developed aminodicarboxylic acid derivatives with promising pharmaceutical properties. These compounds, defined by specific formulae, provide treatments for cardiovascular and fibrotic disorders. Additionally, her work on substituted aminodicarboxylic acid derivatives exemplifies her expertise. This invention covers compounds and their salts and stereoisomers, intended to produce medicaments for treating cardiovascular and various other diseases.

Career Highlights: Cristina's career is marked by her roles at leading companies in the pharmaceutical sector, notably Bayer Aktiengesellschaft and Bayer Healthcare Aktiengesellschaft. Her contributions in these esteemed organizations have led to groundbreaking advancements in drug development.

Collaborations: Throughout her career, Cristina has collaborated with esteemed colleagues such as Johannes-Peter Stasch and Elke Stahl. These partnerships have provided valuable insights and fostered innovation in her work.

Conclusion: Cristina Alonso-Alija's impressive array of patents and collaborations underscores her pivotal role in pharmaceutical innovation. Her contributions have not only advanced the treatment of critical health conditions but also inspire future developments in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…